SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001709401-23-000005
Filing Date
2023-02-27
Accepted
2023-02-27 07:36:15
Documents
80
Period of Report
2022-12-31

Document Format Files

Seq Description Document Type Size
1 10-K ruby-20221231.htm   iXBRL 10-K 1591249
7 EX-21.1 ruby-20221231x10kex211.htm EX-21.1 2860
8 EX-31.1 ruby-20221231x10kex311.htm EX-31.1 11979
9 EX-31.2 ruby-20221231x10kex312.htm EX-31.2 11940
10 EX-32.1 ruby-20221231x10kex321.htm EX-32.1 6030
11 ruby-20221231_g1.jpg GRAPHIC 114206
  Complete submission text file 0001709401-23-000005.txt   7601029

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT ruby-20221231.xsd EX-101.SCH 45343
3 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT ruby-20221231_cal.xml EX-101.CAL 68939
4 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT ruby-20221231_def.xml EX-101.DEF 222089
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT ruby-20221231_lab.xml EX-101.LAB 654850
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT ruby-20221231_pre.xml EX-101.PRE 424498
74 EXTRACTED XBRL INSTANCE DOCUMENT ruby-20221231_htm.xml XML 1104970
Mailing Address C/O VERDOLINO & LOWEY, P.C. 124 WASHINGTON STREET, SUITE 101 FOXBORO MA 02035
Business Address C/O VERDOLINO & LOWEY, P.C. 124 WASHINGTON STREET, SUITE 101 FOXBORO MA 02035 617-679-9600
Rubius Therapeutics, Inc. (Filer) CIK: 0001709401 (see all company filings)

IRS No.: 042688109 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-38586 | Film No.: 23670059
SIC: 2836 Biological Products, (No Diagnostic Substances)